Pharma Industrial India Magazine - May-June 2024

TruDiagnostic Introduces Organ-Specific Aging Analysis from SYMPHONYAge Algorithms Schneider Electric Introduces EcoStruxure for Life Science Segment TruDiagnostic has developed epigen- etic aging analysis of individual organ systems, using validated and sys- tem-specific trained clocks. These algorithms, developed by scien- tists at Yale University, were previously released in biology journal bioRxiv as a preprint, with peer reviewed publica- tions expected later this year. Now known as SYMPHONYAge (Sys - tem Methylation Proxy of Heteroge - neous Organ Years), this collection of system-specific clocks provides a new way of looking at aging by examining how different parts of the body decline independently, and synchronously, over time. Due to lifestyle and dietary choices, re- searchers explain that organ systems age differently in a single body, and that disease-related risks can be calculat - ed by examining 11 major systems and their biological effect on one another. While some biological age tests already claim to predict the extent of aging of various organ systems, SYMPHONYAge is notably different in scope, validation, and associations with various health outcomes. It is also the only published clock which gives organ specific aging information. TruDiagnostic has an ex - clusive license on the use of these al- gorithms which were previously called Systems Clock during earlier stages of research and development. Scientists from Yale University and TruDi - agnostic stress that our body’s systems do not age in isolation, and thus age-re- lated disease and functional decline of- ten do not occur in isolation either. Schneider Electric has released EcoStruxure, a next-generation software technology, for its Life Sciences Seg - ment. This cutting-edge software technology aims to accelerate the efficiency and decarbonization of the pharmaceutical sector by facilitating the transition to Pharma 4.0. By harnessing digital technologies, EcoStruxure for Life Sciences promis - es to reduce up to 70 percent of car - bon emissions by leveraging universal automation to develop smart facilities, manufacturing, supply chains, and sus- tainability. The IoT-enabled solution is designed to drive water conservation, implement process electrification, foster sustainability by design, utilize green electricity, reduce Scope 1, 2, and 3 emissions, and promote circularity. The pharmaceutical industry faces mounting pressure to adopt sustainable practices and minimize its environmen- tal footprint. EcoStruxure for Life Scienc - es aims to enable pharmaceutical pro- duction and biotech facilities to become future-ready by integrating sustainabil- ity, resilience, and agility into their op- erations, accelerating the transition to Pharma 4.0. Speaking at the launch, Arvind Kakru, Vice President – Industrial Automation, Schneider Electric India said, “Schnei - der Electric’s EcoStruxure for Life Sci - ences presents an excellent opportunity for the pharmaceutical sector to collab- orate in achieving the country’s climate goals by embracing Pharma 4.0. Our pioneering solutions will empower our customers and partners to embrace sus- tainability. The launch of our EcoStruxu - re solutions underscores our dedication to engaging with key stakeholders in the pharma industry and guiding them towards the future of Pharma in India.” PRODUCT LAUNCHES PHARMA INDUSTRIALINDIA · MAY-JUN 24 29